The social context of drinking among LGBT+ people
Professor Carol Emslie and David Barbour discuss research on gender, identity and drinking, and the disproportionate impact of substance use in the LGBT+ community.
Cerca
Relazione europea sulla droga 2023: tendenze e sviluppi
La relazione europea sulla droga 2023: tendenze e sviluppi presenta l'ultima analisi dell'OEDT sulla situazione della droga in Europa. Concentrandosi sull'uso di droghe illecite, sui danni correlati e sull'offerta di droga, il rapporto...
Seminar on Youth Participation in Substance Use Prevention
To build an affluent society, the youth must be involved in prevention of substance - Director General, Department of Narcotics Control
Youth is the time for our brain to grow and develop. Using of substances at a young age affect brain...
Commemorazione della giornata "No Smoke" da parte dell'Organizzazione giovanile pakistana
L'Organizzazione giovanile pakistana ha organizzato un seminario alla vigilia della giornata internazionale contro il fumo in collaborazione con il Freedom drug treatment & rehab Centre, Gujranwala Pakistan il 31 maggio 2023 presso Freedom...
Highlights from the 2023 UNODC World Drug Report
ISSUP are pleased to present our Webinar on highlights from the 2023 edition of the UNODC World Drug Report.
Trattamento e prevenzione dei disturbi da uso di sostanze sul posto di lavoro
ISSUP Kenya presenta il suo webinar sull'uso di sostanze sul luogo di lavoro.
MPSP se manifesta contra a descriminalização do porte de drogas para consumo pessoal
Dr. Mario Luiz Sarrubbo, Procurador-Geral da Justiça do Estado de São Paulo, protocolizou um memorial no Supremo Tribunal Federal – STF com o posicionamento do Ministério Público paulista sobre a pauta que trata da possível...
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study
Abstract
Background
The COVID-19 pandemic disrupted healthcare and substance use services engagement, including primary and mental health services as well as residential and outpatient drug treatment. Women who inject drugs (WWID) face...
Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder
Abstract
Importance Suicidal behavior is a significant clinical concern in individuals with borderline personality disorder (BPD), but the effectiveness of pharmacotherapy on reducing suicide risk has remained unknown.
Objective To...
Continuum of Care in Recovery
ISSUP Botswana present their Webinar on Continuum of Care in Recovery.
Resoconti di donne identificate come bevitrici ad "alto rischio" durante la gravidanza
Bere alcolici durante la gravidanza è associato ai disturbi dello spettro alcolico fetale (FASD) e le donne che bevono a livelli più elevati hanno maggiori probabilità di avere un bambino con FASD.
Gli sforzi per comprendere e rispondere...
Webinar sulla prevenzione delle dipendenze per i giovani
L'International Society of Substance Use Professionals (ISSUP) Indonesia e l'Indonesia International Training and Treatment Centre (ITTC) hanno ospitato insieme il secondo webinar su "Prevenzione delle dipendenze per i giovani" domenica 21...
Formazione online INEP Plus in Indonesia
ISSUP Indonesia ha organizzato il corso online Introduction to Evidence-Based Prevention (INEP) come formazione a livello nazionale in Indonesia con 17 partecipanti. La formazione, condotta dalla Dott.ssa Kristiana Siste, SpKJ, e dalla...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides
Para publicación inmediata: 24 de mayo del 2023
Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la inyección subcutánea (para uso por debajo de la piel) de Brixadi...
Covering Substance Use and Addiction Responsibly
Stories about substance use and addiction can be among the thorniest that health and science reporters encounter. This topic carries a long history of marginalizing the people most directly affected. In addition, deeply ingrained societal misconceptions about substance use make it difficult to separate fact from fiction
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Assessment of Medical Cannabis and Health-Related Quality of Life
Abstract
Importance The use of cannabis as a medicine is becoming increasingly prevalent. Given the diverse range of conditions being treated with medical cannabis, as well as the vast array of products and dose forms available, clinical...
SMART recovery for youth: un piccolo studio qualitativo esplorativo che esamina il potenziale di un programma di cambiamento comportamentale di mutuo soccorso e sostegno tra pari per i giovani
Astratto
Sfondo
SMART (Self-Management and Recovery Training) Recovery è un programma di mutuo soccorso informato dalla terapia cognitivo-comportamentale e dal colloquio motivazionale che fornisce supporto per una serie di comportamenti...